MedPath

A STUDY TO KNOW CLINICAL PRESENTATION , RADIOLOGICAL FEATURES AND EFFECTS OF CAROTID ARTERY NARROWING IN STROKE PATIENTS

Not Applicable
Conditions
Health Condition 1: I635- Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteriesHealth Condition 2: I632- Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
Registration Number
CTRI/2022/02/040095
Lead Sponsor
Dr Gangula Charvitha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

INPATIENTS WITH ACUTE ISCHEMIC STROKE DUE TO CAROTID ARTERY STENOSIS

INPATIENT OR OUTPATIENTS WITH TIA WITH SYMPTOMATIC CAROTID ARTERY STENSOSIS

INFARCTION CONFIRMED BY NEUROIMAGING IN TERRITORY OF INTERNAL CAROTID ARTERY

SYMPTOMATIC CAROTID STENOSIS >50% DETECTED BY EITHER CT ANGIOGRAPHY MR ANGIOGRAPHY US CV DOPLLER ACCORDING TO NASCET CRITERIA

Exclusion Criteria

AGE <18 YEARS

PRIMARY INTRACEREBRAL HEMORHAGE

SAH

TUMORS

DEMYELINATION

CHRONIC KIDNEY DISEASE

CHRONIC LIVER DISEASE

SYSTEMIC MALIGNANCY

TOAST CARDIO EMBOLIC STROKE OF OTHER DETERMINED ETIOLOGY SMALL VESSEL OCCLUSIO

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.FUNCTIONAL OUTCOME OF PATIENTS WITH ACUTE ISCHEMIC STROKE WITH SYMPTOMATIC CAROTID STENOSIS WHO ARE MEDICALLY MANAGED VS WHO UNDERWENT STENTING AT 90 DAYS. <br/ ><br>2.NUMBER OF PATIENTS WHO DEVELOPED RECURRENT STROKE WITHIN 90 DAYS IN SYMPTOMATIC CAROTID ARTERY STENOSIS WHO UNDERWENT STENTING VS MEDICALLY MANAGED.Timepoint: 90 DAYS
Secondary Outcome Measures
NameTimeMethod
1.CLINICAL PRESENTATION PROFILE OF PATIENTS WITH SYMPTOMATIC CAROTID ARTERY STENOSIS INCLUDING NIHSS AND mRS GRADING. <br/ ><br>2.RADIOLOGICAL PROFILE OF SYMPTOMATIC CAROTID ARTERY STENOSIS , DEGREE OF STENOSIS , EXTRACRANIAL VS INTRACRANIAL CAROTID STENOSIS <br/ ><br>3.RISK FACTOR PROFILE ASSOCIATED WITH SYMPTOMATIC CAROTID ARTERY STENOSISTimepoint: BASELINE <br/ ><br>12 WEEKS
© Copyright 2025. All Rights Reserved by MedPath